Rogers Echavarria Uceta on Muck Rack

Rogers Echavarria Uceta

As seen in: EMJ- European Medical Journal
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rogers Echavarria

Contact Rogers Echavarria, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

PCSK9 Targeting in the Management of Hypercholesterolaemia

|
By Constantine E. Kosmas, Evangelia Papakonstantinou, Jacqueline Carreño, Rogers Echavarria Uceta
| EMJ- European Medical Journal
1. Proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibodies and inclisiran have ushered in a new, exciting era of hypercholesterolaemia management, addressing several unmet needs. 2. Unprecedentedly low low-density lipoprotein cholesterol concentrations can be achieved with PCSK9 monoclonal antibodies and inclisiran, without any significant safety and tolerability concerns. 3.
Open in Who Shared Issue with article?
See all 1 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Rogers Echavarria

Contact Rogers Echavarria, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified